PRAEGNANT - Prospective Academic translational research network for the optimization of oncological health care quality in the advanced setting. This german study network was set up to take account of some of the recent developments in molecular medicine in the treatment of patients with metastatic breast cancer.
It is an academic registry and translational diagnostics study with the aim to build a healthcare research data base with the objective:
to carry out molecular tests under study conditions
to identify suitable breast cancer patients for clinical trials based on molecular testing
to identify breast cancer patients suitable for clinical trials based on conventional inclusion criteria
to record treatment-induced toxicities and patient´s quality of life in routine clinical practice
to record, show and benchmark the reality of medical care provided to patients with advanced/metastatic breast cancer
PRAEGNANT - Prospective Academic translational research network for the optimization of oncological health care quality in the advanced setting. This german study network was set up to take account of some of the recent developments in molecular medicine in the treatment of patients with metastatic breast cancer.
It is an academic registry and translational diagnostics study with the aim to build a healthcare research data base with the objective:
to carry out molecular tests under study conditions
to identify suitable breast cancer patients for clinical trials based on molecular testing
to identify breast cancer patients suitable for clinical trials based on conventional inclusion criteria
to record treatment-induced toxicities and patient´s quality of life in routine clinical practice
to record, show and benchmark the reality of medical care provided to patients with advanced/metastatic breast cancer
